⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2656136 | 0.98 | CYP1A2 (0.95) | — | |
| Hydrochloric Acid SCHEMBL572907 | 0.98 | CYP1A2 (0.95) | — | |
| Water SCHEMBL28807419 | 0.98 | CYP1A2 (0.95) | — | |
| SCHEMBL1093065 | 0.93 | CYP1A2 (0.87) | — | |
| SCHEMBL4915851 | 0.91 | CYP1A2 (0.83) | — | |
| SCHEMBL2967294 | 0.91 | CYP1A2 (0.83) | — | |
| SCHEMBL4915881 | 0.91 | CYP1A2 (0.83) | — | |
| SCHEMBL3284074 | 0.91 | CYP1A2 (0.83) | — | |
| SCHEMBL1463911 | 0.91 | CYP1A2 (0.83) | — | |
| SCHEMBL7547097 | 0.91 | CYP1A2 (0.83) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-119330874-A | Parsley alkaloid, hybridoma cell strain, antibody and application | 江南大学 | 2025-01-21 | — | — | CN | claimed |
| CN-118724832-A | Preparation method and application of multifunctional fluorescent whitening agent of aminobutyric acid ethyl acrylate | 贺州学院 | 2024-10-01 | — | — | CN | claimed |
| WO-2024065907-A1 | PENTACYCLIC TRITERPENE SAPONIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州大学 | 2024-04-04 | — | — | WO | claimed |
| CN-117304218-A | Synthesis and application of single-excitation double-emission fluorescent probe capable of simultaneously distinguishing imaging cysteine and homocysteine | 湖南师范大学 | 2023-12-29 | — | — | CN | claimed |
| CN-111925298-B | 4-CNAB and preparation method thereof | 无锡紫杉药业有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115710232-A | Compound containing triazolinone structure, preparation method thereof and application of compound as herbicide | 中国农业大学 | 2023-02-24 | — | — | CN | claimed |
| CN-115477681-A | Pentacyclic triterpenoid saponin derivative and preparation method and application thereof | 苏州大学 | 2022-12-16 | — | — | CN | claimed |
| CN-111333641-B | Enhanced fluorescent probe for tetrazine bio-orthogonal labeling and synthesis thereof | 中国科学院大连化学物理研究所 | 2022-05-31 | — | — | CN | claimed |
| EP-3666767-B1 | PHTHALAZINONE DERIVATIVES, METHOD FOR THEIR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING THEM, AND THEIR USE | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2021-12-01 | — | — | EP | claimed |
| US-6989402-B1 | Thyroid receptor ligands and method II | KARO BIO AB (SE) | 2006-01-24 | — | — | US | claimed |
| US-20050282872-A1 | Novel thyroid receptor ligands and method II | HANGELAND JON | 2005-12-22 | — | — | US | claimed |
| EP-1603549-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | Yu, Ruey J., Dr. (US) | 2005-12-14 | — | — | EP | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| CN-1462358-A | Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer | BAYER AG (DE) | 2003-12-17 | — | — | CN | claimed |
| EP-1064253-B1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | claimed |
| US-6346633-B1 | TERT-AMINOPHENYLESTER OF ACID | ASTRAZENECA AB (SE) | 2002-02-12 | — | — | US | claimed |
| EP-1064253-A1 | ANTI-TUMOUR AGENTS | AstraZeneca AB (SE) | 2001-01-03 | — | — | EP | claimed |
| WO-1999048857-A1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 1999-09-30 | — | — | WO | claimed |